Abstract
Background
The aim of this study was to describe the sex- and age-specific prevalence of age-related macular degeneration (AMD) and its correlation with urban or rural residence in a large and relatively young European cohort.
Methods
We evaluated fundus photographs from participants in the Gutenberg Health Study (GHS), a population-based, prospective, observational, single-centre study in the Rhineland-Palatine region in midwestern Germany. The participants were 35–74 years of age at enrolment. The fundus images were classified as described in the Rotterdam Study and were graded independently by two experienced ophthalmologists (CK and UBK) based on the presence of hard and soft drusen, retinal pigmentary abnormalities, and signs of atrophic or neovascular age-related macular generation (AMD).
Results
Photographs from 4,340 participants were available for grading. Small, hard drusen (<63 μm, stages 0b and 0c) were present in 37.4 % of participants (95 % confidence interval [CI], stage 0b, 31.6 % [30.3–33.7]; stage 0c, 5.8 % [5.1–6.5]). Early AMD (soft drusen, pigmentary abnormalities, stages 1–3) was present in 3.8 % of individuals in the youngest age group (35–44 years) (95 % CI, stage 1a, 0.4 % [0.3–0.5 %]; stage 1b, 3.2 % [2.9–3.5 %]; stage 2a, 0.1 % [0.1–0.2 %]; stage 2b, 0 % [0–0.0 %]; stage 3, 0.1 % [0.1–0.2 %]), whereas late AMD (stages 4a and 4b) did not appear in the youngest age group. In all age groups, signs of early AMD were detected in 11.9 % of individuals (stage 1a, 2.1 % [1.7–2.6]; stage 1b, 8.0 % [7.2–8.8]; stage 2a, 1.0 % [0.7–1.3]; stage 2b, 0.5 % [0.3–0.7]; stage 3, 0.3 % [0.2–0.6]). Late AMD (geographic atrophy or neovascular AMD) was found in 0.2 % of individuals (stage 4a, 0.1 % [0.0–0.2]; stage 4b, 0.1 % [0.0–0.2]). AMD increased significantly with age (odds ratio [OR], 1.09; 95 % CI, 1.08–1.10). Sex, iris colour, and residence (rural vs. urban) were not associated with different rates of AMD.
Conclusions
In this study, the prevalence of AMD increased dramatically with age; however, although AMD is usually thought to occur after age 50, signs of early AMD were found in 3.8 % of individuals in the youngest age group (younger than 45 years). This population-based sample is the first to provide substantial epidemiologic data from a large German cohort, including data on macular degeneration in younger age groups and incidence data after recall.
References
Bourla DH, Young TA (2006) Age-related macular degeneration: a practical approach to a challenging disease. J Am Geriatr Soc 54:1130–1135
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379:1728–1738
Heijl A, Algvere PV, Alm A, Andersen N, Bauer B, Carlsson JO, Ehinger B, Eide N, Fledelius H, Foerster M, Hjortdal J, Holmstrom G, Hovding G, Kivela T, la Cour M, Lindblom B, Moller-Pedersen T, Nikoskelainen E, Prause JU, Riise R, Rosenberg T, Seregard S, Stefansson E, Tarkkanen A, Tervo T, Tornqvist K, Zetterstrom C (2005) Nordic research in ophthalmology. Acta Ophthalmol Scand 83:278–288
Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933–943
Finger RP, Fimmers R, Holz FG, Scholl HP (2011) Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol 95:1061–1067
Krumpaszky HG, Klauss V (1996) Epidemiology of blindness and eye disease. Ophthalmologica 210:1–84
Hoehn R, Mirshahi A, Hoffmann EM, Kottler UB, Wild PS, Laubert-Reh D, Pfeiffer N (2013) Distribution of Intraocular Pressure and Its Association with Ocular Features and Cardiovascular Risk Factors: The Gutenberg Health Study. Ophthalmology 120(5):961–968
Mirshahi A, Ponto KA, Hohn R, Wild PS, Pfeiffer N (2013) Ophthalmological aspects of the Gutenberg Health Study (GHS): An interdisciplinary prospective population-based cohort study. Ophthalmologe 110:210–217
Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, Pfeiffer N, Munzel T, Blankenberg S (2012) The Gutenberg Health Study. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 55:824–829
Stang A, Ahrens W, Jockel KH (1999) Control response proportions in population-based case–control studies in Germany. Epidemiology 10:181–183
Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367–374
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851
Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H, Njolstad I (2012) Prevalence of age-related macular degeneration in elderly Caucasians: the Tromso Eye Study. Ophthalmology 119:1737–1743
Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102:205–210
Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102:1450–1460
Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M, Vioque J, Young IS, Fletcher AE (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124:529–535
Klein R, Klein BE, Tomany SC, Moss SE (2002) Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156:589–598
Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116:653–658
Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, Pankow JS, Klein BE (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128:750–758
Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, Tano Y, Mitchell P, Yamashita H, Wong TY (2008) Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology 115:1376–1381, 1381 e1371-1372
Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, Mitchell P, Wong TY (2010) The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117:921–927
Cheung CM, Tai ES, Kawasaki R, Tay WT, Lee JL, Hamzah H, Wong TY (2012) Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort. Arch Ophthalmol 130:480–486
Piermarocchi S, Segato T, Scopa P, Masetto M, Ceca S, Cavarzeran F, Peto T (2011) The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol 18:129–136
Cruickshanks KJ, Klein R, Klein BE, Nondahl DM (2001) Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol 119:246–250
Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C, Chakravarthy U, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J (2008) Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 126:1396–1403
Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT (2004) Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111:1280–1287
Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112:787–798
Tomany SC, Klein R, Klein BE (2003) The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110:1526–1533
Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93:552–558
Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL (1983) Senile macular degeneration: a case–control study. Am J Epidemiol 118:213–227
Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT (2001) Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108:697–704
Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31. doi:10.1186/1471-2415-10-31
Mitchell P, Smith W, Wang JJ (1998) Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 105:1359–1363
Vinding T (1990) Pigmentation of the eye and hair in relation to age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 68:53–58
Klein R, Klein BE, Jensen SC, Cruickshanks KJ (1998) The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116:506–513
Munch IC, Ek J, Kessel L, Sander B, Almind GJ, Brondum-Nielsen K, Linneberg A, Larsen M (2010) Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. Invest Ophthalmol Vis Sci 51:2317–2321
Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Folsom AR (1999) Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 117:1203–1210
Kawasaki R, Wang JJ, Aung T, Tan DT, Mitchell P, Sandar M, Saw SM, Wong TY (2008) Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. Ophthalmology 115:1735–1741
Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134
Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571–580
Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF (2010) Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117:1775–1781
Acknowledgements
Philipp S. Wild is funded by the Federal Ministry of Education and Research (BMBF 01EO1003).
Financial disclosure
The Gutenberg Health Study is funded through the government of Rhineland-Palatine (“Stiftung Rheinland Pfalz für Innovation”, contract number AZ 961-386261/733); the research programs “Wissen schafft Zukunft” and “Schwerpunkt Vaskulaere Praevention” of the University Medical Center Mainz, Germany, and its contract with Boehringer Ingelheim, Germany; and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. The Department of Ophthalmology received a grant from Novartis.
The sponsors and funding organisations did not play any role in the design or conduct of the presented study. All authors have full control of all primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.
Author information
Authors and Affiliations
Corresponding author
Additional information
Christina A. Korb and Ulrike B. Kottler contributed equally.
Rights and permissions
About this article
Cite this article
Korb, C.A., Kottler, U.B., Wolfram, C. et al. Prevalence of age-related macular degeneration in a large European cohort: Results from the population-based Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 252, 1403–1411 (2014). https://doi.org/10.1007/s00417-014-2591-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-014-2591-9